» Articles » PMID: 37566046

Effect of Inflammatory Microenvironment on the Regenerative Capacity of Adipose-Derived Mesenchymal Stem Cells

Overview
Journal Cells
Publisher MDPI
Date 2023 Aug 11
PMID 37566046
Authors
Affiliations
Soon will be listed here.
Abstract

Adipose-derived mesenchymal stem cells are increasingly being used in regenerative medicine as cell therapy targets, including in the treatment of burns and ulcers. The regenerative potential of AD-MSCs and some of their immunological properties are known from in vitro studies; however, in clinical applications, cells are used in non-ideal conditions and can behave differently in inflammatory environments, affecting the efficacy and outcome of therapy. Our aim was to investigate and map the pathways that the inflammatory microenvironment can induce in these cells. High-throughput gene expression assays were performed on AD-MSCs activated with LPS and TNFα. Analysis of RNA-Seq data showed that control, LPS-treated and TNFα-treated samples exhibited distinct gene expression patterns. LPS treatment increased the expression of 926 genes and decreased the expression of 770 genes involved in cell division, DNA repair, the cell cycle, and several metabolic processes. TNFα treatment increased the expression of 174 genes and decreased the expression of 383 genes, which are related to cell division, the immune response, cell proliferation, and differentiation. We also map the biological pathways by further investigating the most altered genes using the Gene Ontology and KEGG databases. Secreted cytokines, which are important in the immunological response, were also examined at the protein level, and a functional assay was performed to assess wound healing. Activated AD-MSC increased the secretion of IL-6, IL-8 and CXCL-10, and also the closure of wounds. AD-MSCs presented accelerated wound healing under inflammation conditions, suggesting that we could use this cell in clinical application.

Citing Articles

Chemoresistance in Pancreatic Cancer: The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes.

Parvaneh S, Miklos V, Pahi Z, Szucs D, Monostori T, Poliska S Int J Mol Sci. 2025; 26(1.

PMID: 39796244 PMC: 11720846. DOI: 10.3390/ijms26010390.


Increased DNA damage of adipose tissue-derived mesenchymal stem cells under inflammatory conditions.

Pahi Z, Szucs D, Miklos V, Ordog N, Monostori T, Varga J Heliyon. 2024; 10(17):e36275.

PMID: 39296022 PMC: 11407982. DOI: 10.1016/j.heliyon.2024.e36275.


Mesenchymal stem cell-based therapy for paraquat-induced lung injury.

Zhang X, Li T, Lu Y Cell Biol Toxicol. 2024; 40(1):70.

PMID: 39136896 PMC: 11322247. DOI: 10.1007/s10565-024-09911-3.


Licensing effects of inflammatory factors and TLR ligands on the regenerative capacity of adipose-derived mesenchymal stem cells.

Szucs D, Monostori T, Miklos V, Pahi Z, Poliska S, Kemeny L Front Cell Dev Biol. 2024; 12:1367242.

PMID: 38606318 PMC: 11007080. DOI: 10.3389/fcell.2024.1367242.


Platelet Concentrates Preconditioning of Mesenchymal Stem Cells and Combined Therapies: Integrating Regenerative Strategies for Enhanced Clinical Applications.

Li X, Xiao H, Wang Z, Tang X, Yu X, Pan Y Cell Transplant. 2024; 33:9636897241235460.

PMID: 38506426 PMC: 10956156. DOI: 10.1177/09636897241235460.


References
1.
Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N . Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019; 76(17):3323-3348. PMC: 11105258. DOI: 10.1007/s00018-019-03125-1. View

2.
Trayhurn P, Drevon C, Eckel J . Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk. Arch Physiol Biochem. 2010; 117(2):47-56. DOI: 10.3109/13813455.2010.535835. View

3.
Cao W, Cao K, Cao J, Wang Y, Shi Y . Mesenchymal stem cells and adaptive immune responses. Immunol Lett. 2015; 168(2):147-53. DOI: 10.1016/j.imlet.2015.06.003. View

4.
Saadh M, Ramirez-Coronel A, Saini R, Arias-Gonzales J, Amin A, Gavilan J . Advances in mesenchymal stem/stromal cell-based therapy and their extracellular vesicles for skin wound healing. Hum Cell. 2023; 36(4):1253-1264. DOI: 10.1007/s13577-023-00904-8. View

5.
Kuca-Warnawin E, Janicka I, Szczesny P, Olesinska M, Bonek K, Gluszko P . Modulation of T-Cell Activation Markers Expression by the Adipose Tissue-Derived Mesenchymal Stem Cells of Patients with Rheumatic Diseases. Cell Transplant. 2020; 29:963689720945682. PMC: 7784571. DOI: 10.1177/0963689720945682. View